Retrieve available abstracts of 9 articles: HTML format
Single Articles
February 2025
VIJIARATNAM N, Girges C, Auld G, McComish R, et al Exenatide once a week versus placebo as a potential disease-modifying treatment
for people with Parkinson's disease in the UK: a phase 3, multicentre,
double-blind, parallel-group, randomised, placebo-controlled trial.
Lancet. 2025 Feb 4:S0140-6736(24)02808-3. doi: 10.1016/S0140-6736(24)02808. PubMedAbstract available
August 2024
MARRAS C, Ben-Shlomo Y, Darweesh SKL, Llibre-Guerra J, et al Validity of the diagnostic criteria for Parkinson's disease - Authors' reply.
Lancet. 2024;404:652-653. PubMed
HE Y, Wang JG, Gao CQ Validity of the diagnostic criteria for Parkinson's disease.
Lancet. 2024;404:652. PubMed
January 2024
FOLTYNIE T, Bruno V, Fox S, Kuhn AA, et al Medical, surgical, and physical treatments for Parkinson's disease.
Lancet. 2024;403:305-324. PubMedAbstract available
MORRIS HR, Spillantini MG, Sue CM, Williams-Gray CH, et al The pathogenesis of Parkinson's disease.
Lancet. 2024;403:293-304. PubMedAbstract available
BEN-SHLOMO Y, Darweesh S, Llibre-Guerra J, Marras C, et al The epidemiology of Parkinson's disease.
Lancet. 2024;403:283-292. PubMedAbstract available
THE LANCET What next in Parkinson's disease?
Lancet. 2024;403:219. PubMed
October 2023
VERHOEFF MC, Berendse HW, Lobbezoo F The importance of a healthy mouth in Parkinson's disease.
Lancet. 2023;402:1419-1420. PubMed
February 2023
FERREIRA D, Araujo R A professional sportsperson with subtle motor symptoms and signs: early-onset
Parkinson's disease.
Lancet. 2023;401:e18. PubMed